Also, treatment of mice with harmol proved to be safe, and improved glucose tolerance, insulin sensitivity, adipokine profile and liver lipid accumulation in a model of diet-induced obesity and pre-diabetes (Fig. 5), resembling the beneficial effects of metformin, a well-known anti-diabetic mitohormetic used in the clinic. Here, INS is linked to diabetes mellitus.